WELCOME

Medidelta Inc. is dedicated to researching new technologies for the early diagnosis of diseases. One of the new technologies we developed is Cytopath.

Cytopath is a cervical cancer screening system developed for the scanning of conventionally prepared Pap smears. This automated software provides an accurate, reliable, flexible and cost-effective solution which can easily be introduced into any existing screening program.

More information can be found here in our Products section.